Literature DB >> 12584964

Lack of awareness and nonadherence in schizophrenia.

Yoriko Kozuki1, Erika Sivarajan Froelicher.   

Abstract

This cross-sectional study examines whether lack of awareness of symptoms is a predictor for nonadherence. The study consecutively recruited 134 participants with Diagnostic and Statistical Manual of Mental Disorders, 4th edition, diagnoses of schizophrenia spectrum disorders at acute psychiatric units. Outcome was measured by a combination of self-reports, utilizing the Rating on Medication Influences and medical records. The univariate analysis showed that homelessness was a predictor for nonadherence (p = .03). The subsequent logistic regression showed that the multidimension symptom lack of awareness score was significantly associated with nonadherence to psychotropic medications (odds ratio = 0.59, 95% Confidence Interval = 0.35, 0.96). Other clinical and demographic variables as well as subjective responses were not significant predictors of nonadherence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584964     DOI: 10.1177/0193945902238836

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.967


  10 in total

Review 1.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

2.  Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.

Authors:  Christine M Wilder; Eric B Elbogen; Lorna L Moser; Jeffrey W Swanson; Marvin S Swartz
Journal:  Psychiatr Serv       Date:  2010-04       Impact factor: 3.084

3.  Integration of collaborative medication therapy management in a safety net patient-centered medical home.

Authors:  Leticia R Moczygemba; Jean-Venable R Goode; Sharon B S Gatewood; Robert D Osborn; Akash J Alexander; Amy K Kennedy; Lisa P Stevens; Gary R Matzke
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Mar-Apr

4.  Development and Implementation of an Academic-Community Partnership to Enhance Care among Homeless Persons.

Authors:  Sharon B S Gatewood; Leticia R Moczygemba; Akash J Alexander; Robert D Osborn; Dianne L Reynolds-Cane; Gary R Matzke; Jean-Venable R Goode
Journal:  Innov Pharm       Date:  2011

5.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

6.  An approach to maximizing treatment adherence of children and adolescents with psychotic disorders and major mood disorders.

Authors:  Robin Edward Gearing; Irfan A Mian
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2005-11

7.  Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.

Authors:  Menna Alene; Michael D Wiese; Mulugeta T Angamo; Beata V Bajorek; Elias A Yesuf; Nasir Tajure Wabe
Journal:  BMC Clin Pharmacol       Date:  2012-06-18

8.  Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation.

Authors:  Ernst L Noordraven; André I Wierdsma; Peter Blanken; Anthony Ft Bloemendaal; Cornelis L Mulder
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-03       Impact factor: 2.570

9.  Clozapine for severe ("kraepelinian") schizophrenia: Sustained improvement over 5 years.

Authors:  Ricardo de Oliveira-Souza; Rogério Paysano Marrocos; Jorge Moll
Journal:  Dement Neuropsychol       Date:  2008 Jan-Mar

10.  Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.

Authors:  Julien Elowe; Julie Ramain; Alessandra Solida; Philippe Conus; Philippe Golay
Journal:  Eur Psychiatry       Date:  2022-08-15       Impact factor: 7.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.